Medicure Inc. announced the appointment of Mr. Haaris Uddin (CPA, B.Comm.) as Chief Financial Officer, effective June 1, 2022. Mr. Uddin as Chief Financial Officer, he began his career with Ernst & Young LLP as a senior accountant in assurance services and brings experience in public company reporting within the life sciences industry in both Canada and the United States.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 CAD | +9.52% | +7.48% | -17.86% |
Apr. 09 | Transcript : Medicure Inc., 2023 Earnings Call, Apr 09, 2024 | |
Apr. 08 | Medicure Swung to a Loss in 2023 on Lower Sales | MT |
1st Jan change | Capi. | |
---|---|---|
-17.86% | 8.78M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MPH Stock
- News Medicure Inc.
- Medicure Inc. Appoints Haaris Uddin as Chief Financial Officer, Effective June 1, 2022